CN Patent
CN108864078B — 帕博西尼晶型b的制备方法
Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2021-10-15 · 5y expired
What this patent protects
本发明涉及一种帕博西尼晶型B的制备方法,将帕博西尼的有机酸或无机酸盐溶于水,一定温度下与碱性物质水溶液反应游离得到帕博西尼晶型B。本发明制备的帕博西尼晶型B具有较大的比表面积,非常适合药用。本发明制备工艺简单、稳定、可靠,非常适合工业化生产。
USPTO Abstract
本发明涉及一种帕博西尼晶型B的制备方法,将帕博西尼的有机酸或无机酸盐溶于水,一定温度下与碱性物质水溶液反应游离得到帕博西尼晶型B。本发明制备的帕博西尼晶型B具有较大的比表面积,非常适合药用。本发明制备工艺简单、稳定、可靠,非常适合工业化生产。
Drugs covered by this patent
- Palbociclib (palbociclib) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.